Maravai LifeSciences Announces November 2025 Investor Conference Schedule

SAN DIEGO--(BUSINESS WIRE)-- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of November.

On November 12, 2025, at 10:00 a.m. EST, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference in New York City, NY.

On November 19, 2025, at 10:00 a.m. GMT, Raj Asarpota, Chief Financial Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in London, England.

A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, IR Calendar. An archived version of the webcast will also be available on the Maravai website after the event is completed.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251110174821/en/

Investor Contact:
Deb Hart
Maravai LifeSciences
+1 858-988-5917
[email protected]

Source: Maravai LifeSciences, Inc.

You May Also Be Interested In

• Alibaba Group Announced Pricing of HK$80 Billion Placing of New Shares in Hong Kong
• pixelgrinder Announces Second Full-Length Album “White Mask” for September 25 Release
• She Made it – the Youngest South African Woman to Swim the Channel